Use access key #2 to skip to page content.
$42.95 0.90 (2.14%)
5/12/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AMGN

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

1555 Outperforms
137 Underperforms
 

All-Stars

400 Outperforms
28 Underperforms
 

Wall Street

14 Outperforms
1 Underperforms
 

Players bullish on AMGN are also bullish on:

Players bearish on AMGN are also bearish on:

Ticker Tags

Rule Breakers Universe (161), Biotechnology (291), Thousand Oaks (1), S&P 500 (484), Large Cap (467), Dermatology (7), Nasdaq 100 (99), Mega Cap (146), Business Week 50 (50), Serial Acquirer (9), California (41)
Suggest a tag

Amgen, Inc. At A Glance

Current Price: $42.95
Last Trade Time: 5/12/2008 4:00 PM
Open: $41.86
Previous Close: $42.05
Daily Range: $41.86 - $43.05
52-Week Range: $39.16 - $62.72
Volume: 5,997,201
Market Cap: $45.75B
P/E Ratio: 14.70
Compare Our Special Broker Offers!

Stock Trends

AMGN VS S&P 500 (SPY)

AMGN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for AMGN

More Headlines...

Top Bull Pitch

Recs

6

Amgen, Inc. (AMGN)

Avatar DemonDoug (99.97) Submitted: 12/18/07 1:41 PM

A bit risky maybe. Amgen is a solid company with a good portfolio of drugs and a history of good science and innovation. Appears to have bottomed, although I'm not a technical trader. I like Amgen as a company though, as I understand it the work environment is very supportive and is a great compa...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Amgen, Inc. (AMGN)

Avatar Jorgedig (56.68) Submitted: 12/01/07 12:25 PM

I sold my Amgen just before the new, strict Medicare guidelines came through on the use of Aranesp to treat chemotherapy-induced anemia.





I work in a cancer clinic, and we are very concerned that many of our patients are denied this important drug until their hematocrits are ...More

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 317 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AMGN)

Avatar satur9nine (58.46) Submitted: 5/09/08 2:07 AM : Outperform Start Price: $41.67 AMGN Score: 1.58

Plenty of drugs in the pipeline, it may be many years before this pays off.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar benz536 (39.68) Submitted: 5/07/08 1:33 PM : Outperform Start Price: $42.13 AMGN Score: 2.27

At year low, has good pipeline oversold

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar JustWokeUp (42.77) Submitted: 5/06/08 9:30 PM : Underperform Start Price: $42.97 AMGN Score: -1.01

AMGN was a great company with a great list of drugs and developments.

However the momentum is now gone (it has gone for a couple of months) and what's left is speculations that other drugs in the pipeline will become the next blockbuster. As the regulations tighten and more and more restrictions are made (e.g. on Aranesp use), AMGN is not going to move up for the next couple of months, at least. Wait for the stock to pass $45 to make a buy.

Unless some sudden great news emerge.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar ADertsakian (60.66) Submitted: 5/02/08 7:37 PM : Outperform Start Price: $42.93 AMGN Score: 0.46

Amgen is still one of the best Bio stocks available. It is only a matter of time before their new products hot the market and lift this stock above 60-70.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMGN)

Avatar BobLangley (60.73) Submitted: 5/02/08 12:29 AM : Outperform Start Price: $43.41 AMGN Score: -0.51

If drugs in the pipeline help AMGN return to anything like its historical P/E ratio, it should do much better than it currently is.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 317 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 15 of 15  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 81.00 01/18/08 Underperform 3W $47.45-9.48%+6.26%+15.74
TrackDodgeCox 93.10 12/31/07 Outperform NS $46.44-7.52%-3.93%-3.58 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 86.05 11/15/07 Outperform NS $54.33-20.95%-4.17%-16.78
TrackCreditSuiss 94.99 10/24/07 Outperform NS $57.80-25.69%-7.11%-18.58
TrackDreman 94.45 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 86.50 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ 29.20 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena < 20 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 71.22 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackHillman 39.06 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 83.04 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackChrisDavis 38.29 09/30/07 Outperform NS $56.57-24.08%-7.94%-16.13 Toggle the visibility of 60-Second Pitch and replies
TrackMichaelSivy 53.58 03/20/07 Outperform 1Y $55.85-23.10%-0.36%-22.74
TrackBearStearns 93.79 01/04/07 Outperform NS $69.99-38.63%+0.02%-38.66

Results 1 - 15 of 15  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners